However, in SCH groups, the decrease in CD8+ and CD4+ T cells was followed by an increase, suggesting that SCH had an impact on immunological enhancement, which was uniformly shown in the HD‐SCH group Figure 5B–D. The gene discussed is CD8A; the disease is Huntington disease.